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Serum response factor (SRF) is a transcription factor
that controls the expression of cytoskeletal proteins
and immediate early genes in different cell types.
Here, we found that SRF expression is restricted to
endothelial cells (ECs) of small vessels such as capil-
laries in the mouse embryo. EC-specific Srf deletion
led to aneurysms and hemorrhages from 11.5 days
of mouse development (E11.5) and lethality at
E14.5.Mutant embryospresenteda reducedcapillary
density and defects in ECmigration, with fewer num-
bers of filopodia in tip cells and ECs showing defects
in actin polymerization and intercellular junctions.We
show that SRF is essential for the expression of VE-
cadherin and b-actin in ECs both in vivo and in vitro.
Moreover, knockdown of SRF in ECs impaired
VEGF- and FGF-induced in vitro angiogenesis. Taken
together, our results demonstrate that SRF plays an
important role in sprouting angiogenesis and small
vessel integrity in the mouse embryo.
INTRODUCTION
Embryonic development depends on the establishment of
a functional network of blood vessels for the transport of oxygen,
nutrients, signaling molecules, circulating cells, and metabolic
waste products between tissues and organs. The malformation
or dysfunction of this network contributes to the pathogenesis
of many diseases (Carmeliet, 2005). Embryonic blood vascula-
ture tree formation involves two fundamentally different pro-
cesses. Initially, vasculogenesis gives rise to a primary vascular
plexus through the differentiation of precursor cells named he-
mangioblasts. Subsequently, angiogenesis leads to the forma-
tion of a complex vascular tree of variably sized vessels through
tight coordination of cell proliferation, differentiation, migration,
matrix adhesion, and the recruitment of mural cells (Hanahan
and Folkman, 1996; Risau, 1997). Various signaling molecules,
such as VEGF, FGF, TGF-b, PDGF, angiopoietins, Dll4, ephrins,
netrins, semaphorins, and slit, have proven crucial in vascular
tree development (Adams and Alitalo, 2007; Eichmann et al.,
2005; Torres-Va´zquez et al., 2004). These signaling pathways
elicit an array of biological effects and intracellular signaling448 Developmental Cell 15, 448–461, September 16, 2008 ª2008 Eevents that mediate their function in endothelial cells (ECs).
The ultimate downstream effectors of these signaling pathways
are transcription factors.To date,no EC-specific transcription fac-
tors have been identified, and it has been suggested that a combi-
nation of several transcription factors, such as Hox, FoxO, Ets,
and GATA family members, as well as Vezf-1, SCL/Tal1, and
Hey1 and 2, control gene expression in ECs (Dejana et al.,
2007). Serum response factor (SRF) is an ancient and evolution-
arily conserved transcription factor of the MADS-box family that
binds to a CArG box (CC(A/T)6GG) found in the regulatory
regions of multiple genes involved in cell growth, migration,
cytoskeletal organization, energy metabolism, and myogenesis
(Treisman,1987; Sunet al., 2006). The regulation of suchdivergent
processes by SRF relies on its ability to associate with different
cell-type-specific and signaling-responsive accessory cofactors
or transcription factors, such as members of the Ets, myocardin,
and GATA families. In addition, SRF mediates the activity of cyto-
kines like endothelin-1 and angiotensin II, growth factors including
PDGF and TGF-b, and catecholamines (Chai and Tarnawski,
2002; Miano, 2003). Tarnawski’s group demonstrated that VEGF
induces SRF expression and nuclear translocation and increases
SRF-binding activity to the CArG box in ECs in vitro through both
Rho-Actin and MEK-ERK signaling pathways (Chai et al., 2004). In
this context, SRF is a downstream mediator of VEGF signaling in
ECs and is required for VEGF-induced angiogenesis.
Classical disruption of theSrf gene in mice leads to an early em-
bryonic death witha defect inmesodermformation (Arsenianetal.,
1998). Using a conditional Cre/loxP gene inactivation system, we
and other groups have demonstrated the crucial role of SRF during
embryogenesis for differentiation and for maturation of cardiac
and smooth muscle cells (SMCs) (Parlakian et al., 2004; Miano
et al., 2004; Niu et al., 2005). The role of SRF in the developing
vascular system is, however, unknown. In order to investigate
this further, we used the transgenic mouse line Tie1-Cre (Gustafs-
son et al., 2001) to trigger the specific loss of SRF in ECs. Here, we
show that SRF expression is restricted to ECs of small vessels in
the mouse embryo, and that SRF is particularly important for the
expression of b-actin and VE-cadherin in ECs. Inactivation of the
Srf gene in embryonic ECs leads to a decrease in the number of
branching points, alterations in tip cellmorphology, and the disrup-
tion of EC junctions. These defects result in aneurysm and hemor-
rhage formation in small vessels found predominantly in the limb
buds, head, and tail, which ultimately leads to embryonic lethality
at E14.5. Our results suggest a crucial role for SRF in sprouting
angiogenesis and in the maintenance of small vessel integrity.lsevier Inc.
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Role of SRF in Sprouting AngiogenesisFigure 1. SRF Protein Is Detected Only in the ECs of Small Vessels in the Mouse Embryos
(A–F) Immunofluorescence images of anti-SRF antibodies (green), anti-PECAM1 (red) antibodies, and DAPI staining (blue) in E11.5 embryos. SRF is present in (A)
ECs (arrows) of small vessels and the perineural vascular plexus, but not in (B) ECs of large vessels, like the aorta or cava vein. SMCs in the aorta are SRF positive
(arrowheads). Inserts are a higher magnification of the regions indicated in (A) and (B). (C–F) Confocal images of hindbrain capillaries showing a strong expression
of SRF in tip and stalk ECs of sprouting vessels. Tip cells are indicated by white arrows, and stalk cells are indicated by yellow arrows. (E and F) Higher magni-
fication of sprouting capillaries. Cv, cava vein; nt-vp, neural tube vascular plexus. The scale bars are 25 mm in (A) and (B), 200 mm in (C) and (D), and 10 mm in (E)
and (F).RESULTS
ECs of Small Vessels Express SRF Protein
in the Mouse Embryo
Using immunohistochemistry, we analyzed the expression of
SRF in the vascular system of the mouse embryo (Figure 1).
We found SRF expression in ECs of small vessels (diameter <
25 mm), the capillaries, arterioles, and venules (Figure 1A and
data not shown), although not in ECs of large vessels (Figure 1B),
such as the aorta and cava veins, in which SRF was only
detected in SMCs. Interestingly, we observed SRF expression
in both stalk and tip cells of sprouting capillaries, such as the
hindbrain capillaries (Figures 1C–1F). This particular pattern of
SRF protein expression suggests a specific role of SRF in the
ECs of embryonic small vessels.
EC-Specific SRF Deletion Leads to Hemorrhage
and Death at E14.5
To inactivate the Srf gene in ECs, we crossed SRF-floxed (ab-
breviated Sf/Sf) mice with the Tie1-Cre mice that express Cre in
ECs as soon as E8.0 and in a minor population of hematopoi-Developmeetic cells (Gustafsson et al., 2001). The resulting Sf/+:Tie1-Cre
double transgenic mice were viable. Intercrosses of Sf/+:Tie1-
Cre males with Sf/Sf females (Figure 2A) yielded no Sf/Sf:
Tie1-Cre pups (thereafter designated as SRFECKO or mutant)
out of 151 viable offspring at birth. To determine when the
SRFECKO embryos died, we examined litters from E8.5 to birth
and obtained Mendelian ratios for the four possible genotypes
(Sf/Sf, Sf/Sf:Tie1-Cre, Sf/+, and Sf/+:Tie1-Cre) between E8.5
and E13.5 (data not shown). PCR analysis from embryonic
DNA indicated the deletion of the Srf gene as early as E8.5
(Figure 2B).
SRFECKO embryos from E8.5 to E10.5 were macroscopically
indistinguishable from the control littermates (Figures 2C and
2D). Macroscopic examination revealed the presence of micro-
hemorrhages and hematomas in the SRFECKO embryos that
increased in size and number with age between E11.5 and
E14.5. Large hematomas formed with high frequency at the
limb buds, the tip of the tail, and the forebrain (arrows in Fig-
ure 2C). Extensive multifocal subcutaneous hemorrhages ap-
peared at E13.5 and E14.5. Examination of histological sections
revealed disrupted vessels with the diffusion of red blood cellsntal Cell 15, 448–461, September 16, 2008 ª2008 Elsevier Inc. 449
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Role of SRF in Sprouting Angiogenesisinto the perineural mesenchyme (Figure 2, compare [K] and [L] to
[E] and [F]) and the subcutaneous capillaries (data not shown).
We also observed extensive dilatations of intraneural capillaries,
with or without endothelium rupture (Figure 2, compare [M] and
[N] to [G] and [H]). The very large pouches of blood frequently
Figure 2. Tie1-Cre-Mediated Inactivation of
SRF Leads to Capillary Aneurysms and
Hemorrhages in the Mouse Embryo
(A) Schematic representation of Cre-mediated
SRF exon 2 inactivation strategy.
(B) Genomic PCR analysis of the Srf gene on DNA
of E8.5 embryos resulting from Sf/+:Tie1-Cre
crossed with Sf/Sf. The four different genotypes
([1] Sf/+, [2] Sf/Sf, [3] Sf/+:Tie-Cre1, and [4]
Sf/Sf :Tie-Cre1) were represented. The fragments
corresponding to the floxed (flox), wild-type
(wt), or deleted (del) exon 2 of the Srf gene are
indicated.
(C and D) Whole-mount view of mutant and
control embryos from E10.5 to E14.5. Hemor-
rhagic lesions in the forebrain region (arrows),
limb buds, and tail were observed in E11.5
embryos.
(E–P) Histological analysis of (E–J) control and
(K–P) mutant embryos. (F), (H), (J), (K), (M), and
(O) are higher magnifications of the regions indi-
cated in (E), (G), (I), (L), (N), and (P), respectively.
Two types of vascular defects were observed in
mutant embryos: (i) broken capillaries, as seen
in the peri-neural vascular plexus (compare [K]
and [L] to [E] and [F]), characterized by the (K
and L) presence of blood cells (star) within
mesenchyme; (ii) dilatation of vessels with the
accumulation of red blood cells. Variable lumen
enlargement of neural tube capillaries (compare
[M] and [N] to [G] and [H]) and the extreme
enlargement of the marginal vein in the limb
bud (compare [O] and [P] to [I] and [J]) are
presented.
The scale bars are 1 mm in (E), (G), (I), (L),
and (N) and 100 mm in (P), (F), (H), (J), (K), (M),
and (O).
observed in the limb buds were due to
a dilatation of the marginal vein (Figure 2,
compare [O] and [P] to [I] and [J]). This
dilatation appeared secondary to malfor-
mations of the marginal vein. In fact,
blood flow in the marginal vein of mutant
embryos became bidirectional instead
of unidirectional, as observed in controls
(see Movies S1–S4 available online).
Analysis of serial histological sections in-
dicated an intact EC layer in most cases,
thus suggesting a local dilatation of the
vascular wall. We also found aneurysmal
structures at the tip of the tail that
are lined by a continuous endothelium
(Figure 4G). A reduced rate of blood
flow due to vessel malformations in the
cephalic veins led to thrombus formation
(Movie S5).
In agreement with the absence of SRF in the ECs of the aorta
and cava vein, the formation and the stability of these vessels
were not affected in SRFECKO embryos. We found no hemor-
rhagic or aneurysm defects in the extraembryonic vasculature
of the mutant embryo (data not shown).450 Developmental Cell 15, 448–461, September 16, 2008 ª2008 Elsevier Inc.
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Role of SRF in Sprouting AngiogenesisFigure 3. Reduced Vascular Capillary Net-
work Density in SRFECKO Embryos
(A and B) Whole-mount view of X-gal staining of
E9.5 (A) Sf/+:Tie1-Cre:R26/+ and (B) Sf/Sf :Tie1-
Cre:R26/+ (mutant) triple transgenic embryos.
(C and D) Higher magnification of boxed regions in
(A) and (B), respectively. We observed no obvious
defect between mutant and control embryos at
E9.5.
(E and F) Whole-mount immunohistochemical
staining by anti-PECAM1 antibody on E11.5
embryos. Hemorrhagic lesions were indicated by
arrows.
(G and H) Higher magnification of boxed regions in
(E) and (F), respectively, show the reduction of
vascular network density in the intersomitic region
(arrows).
(I and J) Confocal immunofluorescence images of
the (I) control and (J) mutant limb buds with anti-
PECAM1 antibody on E11.5 embryos show similar
branching reduction.
(K and L) Higher magnification of boxed regions in
(I) and (J), respectively.
(M and N) Confocal images of hindbrain of E11.5
embryos labeled by isolectin B4 also show a
reduced capillary density in mutant embryos.
mdl, midline.
(O) Quantification of the number of branching
points of the different regions at E9.5, E10.5, and
E11.5. The data shown are means ± SEM. N = 6,
*p < 0.05.
(P) Quantification of intercapillary space in limb
buds of E11.5 control and mutant embryos. The
data shown are means ± SEM. N = 6, *p < 0.05.
The scale bars are 250 mm in (C), (D), (G), (H), (I), (J),
(M), and (N) and 100 mm in (K) and (L).Reduced Vascular Branching and Increased
Intercapillary Spaces in Mutant Embryos
In order to follow the fate of the ECs and compare the pattern
of the vascular network in mutant and control embryos, we
used the ROSA26 (R26) reporter line (Soriano, 1999). We crossed
the Sf/+:Tie1-Cre males with homozygous Sf/Sf:R26/R26 fe-
males to generate Sf/+:Tie1-Cre:R26/+ (control) and Sf/Sf:Tie1-
Cre:R26/+ (mutant) triple transgenic embryos. The E8.5 and
E9.5 mutant embryos showed no obvious vascular defects, as
indicated by the whole-mount X-gal coloration (Figures 3A–3D;
Figure S1). However, a reduction in capillary density started at
E10.5 and preceded the appearance of hemorrhagic lesions, ar-
guing for a primary defect in sprouting angiogenesis in SRFECKO
embryos. Whole-mount staining with an anti-PECAM1 antibody
(Figures 3E–3H and 3I–3N) confirmed this observation. Quantifi-
cation of the number of branching points in the intersomitic re-
gion of the trunk revealed a progressive decrease in the mutant
starting at E10.5, reaching 50% that of controls by E11.5
(Figure 3O). Other regions of the embryo, such as the limb
buds and hindbrain, also showed a similar decrease at this stage
(Figures 3I–3O). Accordingly, the intercapillary area was larger in
the mutant (Figure 3P). These results indicate a severely compro-
mised capillary angiogenesis in SRFECKO embryos, whereas
large vessels arising through vasculogenesis were unaffected.DevelopmDetailed Analysis of Angiogenic Defects and Aneurysm
Formation in the Tail
Vessels in the tail form in a sequential and stereotypic manner
that parallels the temporal order of somite formation, thus allow-
ing a detailed analysis of the vascular defects. We observed
the vascular network of the tail in Sf/+:Tie1-Cre:R26/+ control
embryos at E11.5. As depicted in the schematic drawing (Fig-
ure 4A), the posterior ends of the paired caudal arteries connect
to dorsolateral vessels that are themselves interconnected at the
tip of the tail to form a half-circular tip vessel (also see Figure 4C).
A dense capillary network branches out of the caudal vein,
located ventral to the caudal artery, to join the dorsolateral ves-
sels on each side of the tail (Figures 4A and 4B). In the SRFECKO
embryos, however, we found a large decrease in the density of
the capillary network joining the caudal vein to the dorsolateral
vessel (Figure 4D), as well as irregularly shaped dorsolateral ves-
sels that did not join at the tip of the tail (Figure 4E), but instead
ballooned at the posterior end (stars, Figures 4D, 4E, 4G, and
4H). Whole-mount anti-PECAM1 staining of the tail at E12.5
showed the sizeable extent of this dilatation enclosing the
ends of the caudal arteries and vein at this stage (Figure 4G).
The intersomitic arteries branching from the caudal aorta devel-
oped normally in the SRFECKO embryo. In contrast, we found de-
fects at the level of the secondary branches. The dorsolateralental Cell 15, 448–461, September 16, 2008 ª2008 Elsevier Inc. 451
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Role of SRF in Sprouting AngiogenesisFigure 4. Aneurysm Formation Is Associated with Defective Sprout-
ing Angiogenesis and Capillary Connections in the Tail
(A) Schematic drawing of vascular network development in the region near the
tip of the tail (see Results section for details). Anterior-posterior (A-P) and
left-right (L-R) axes are indicated.
(B–E) X-gal staining of E11.5 (B and C) Sf/+:Tie1-Cre:R26/+ and (D and E)
Sf/Sf:Tie1-Cre:R26/+ triple transgenic embryos. We observed a reduction in
capillary density of the dorsolateral vessels (dlv) and irregularly shaped dorso-
lateral vessels without the formation of a half-circular tip vessel (tv).
(F and G) Confocal images of the left lateral view of whole-mount immunoflu-
orescence of E12.5 control and mutant embryo tails, with PECAM1 antibody.
Defects were found at the level of the secondary branches in the mutant tail.
Note the aneurysm-like dilation at the end of the caudal arteries and vein
boundary region (star), as well as the anarchical connections of secondary
branches of intersomitic vessels ([G], arrows), contrasting with the linear link
of the dorsolateral vessels in control tail ([F], arrows).452 Developmental Cell 15, 448–461, September 16, 2008 ª2008 Elbranches of the mutant were misaligned and discontinuous
(Figure 4G) compared to the linear vessel formation found in
the control (Figure 4F). In addition, the dorsomedial vessels con-
necting the dorsal ends of the intersomitic arteries on either side
of the neural tube also showed defects in the mutant embryos. In
controls, these vessels arise by sprouting angiogenesis, begin-
ning at the level of somites 6–7 (the last forming somite near
the tail tip is designated as number 1) and connecting over
somite 8 (Figure 4I). In the mutants, we instead observed
PECAM1-positive pouches at the dorsal end of the intersomitic
arteries (Figure 4H, arrowheads). Using the Vim-nls-lacZ trans-
gene (Colucci-Guyon et al., 1994) to label EC nuclei, we con-
firmed that the pouches were covered by ECs in mutant embryos
(Figure 4J, arrowheads). Our observations suggest that the lack
of SRF in ECs impairs sprouting angiogenesis at the tip of small
vessels, thereby locally altering the connections between arteries
and veins. Blood circulation is likely impaired in such a deficient
network, and the tips of vessels are more prone to dilatation.
Altered EC-Specific Gene Expression
in the Mutant Embryos
To investigate the consequence of targeted SRF inactivation on
EC gene expression, we performed a real-time RT-PCR screen
on a set of 41 genes mainly involved in EC functions (Figure 5A).
RNA was extracted from limb buds of mutant and control em-
bryos of the same litter. At E12.5, we found a 28% reduction of
SrfmRNA in the mutant limb buds. This relatively low SRF reduc-
tion can be explained by the presence of other cells expressing
SRF in the samples, such as muscle, mesenchymal, and epithe-
lial cells. We found 21 significantly downregulated genes in the
mutant. The transcriptional regulators Creb1 and Hdac7a
showed a 30%–40% reduction, whereas that of c-fos and
Vezf1 was not significant. We found a significant downregulation
of b-actin, but not for muscle-specific genes such as smooth
muscle a-actin and desmin. The aneurysms and microhemorrh-
ages in histological sections prompted us to look at the expres-
sion of proteins involved in cell-cell and cell-matrix interactions in
the SRFECKO. Mutants showed a 30% decrease in the mRNA
level of genes encoding junctional proteins, such as VE-cad-
herin, ZO-1, and occludin, as well as b1-, a1-, and a5-integrins,
whereas the expression level of Pecam1 and ZO-3 was un-
changed. We examined the expression of several genes encod-
ing proteins involved in signaling pathways in ECs. The expres-
sion level of Alk1, Alk5, endoglin, angiopoietins 1 and 2, Vegfb,
Vegfr2, Pdgfb, and Pdgfrb was significantly decreased. Expres-
sion levels of Tgfb1, Tgfbr2, Tie2, Vegfa, Vegfr1, Pdgfa, Edg1,
and Edg5 showed no significant change. The expression of
(H) Confocal microscope image of PECAM1 immunostaining in the E12.5
mutant embryo confirmed the presence of aneurysm-like structures at the
tail tip (star) and at the tips of intersomitic arteries (arrowheads).
(I and J) X-gal staining of the E12.5 triple transgenic embryos (I) Sf/+:Tie1-
Cre:Vim-nls-lacZ and (J) Sf/Sf:Tie1-Cre:Vim-nls-lacZ (mutant). The nuclei of
ECs are marked in blue. The aneurysm-like defects are observed once more
and seemed to be time dependent (arrowheads in [J]). These defects were
only observed in five formed somites (n 6–10). The last forming somite near
the tail tip is designated number 1 in (H)–(J). No real connection of dorsomedial
vessels (dmv) between neighboring somites was observed in the region
containing aneurysm-like defects.
The scale bars are 250 mm.sevier Inc.
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Role of SRF in Sprouting AngiogenesisFigure 5. Altered Gene Expression in SRFECKO Embryos
(A) Quantification of mRNA levels in limb buds of E12.5 embryos by semiquantitative RT-PCR. All genes are normalized to GAPDH. The RNA level obtained for
control limb buds was set to 1, and the ratios of mutant versus control limb buds is presented for each gene. The error bars represent SEM; N = 5, (*): p < 0.05
Student test.
(B) Western blot analysis of E12.5 embryo limb buds. Representative western blot analysis of control and mutant embryos is presented.
(C) The relative protein level of mutant versus control is presented. The level of control samples was set to 1. The error bars represent SEM; N = 6, (*): p < 0.05
Student test.
(D) ChIP analysis of SRF binding to murine genomic VE-cadherin,Alk1, and Alk5CArG elements in ECs. The sequences and positions of the putative SRF-binding
sites found in the promoters and the downstream transcription start site (TSS) are indicated.Developmental Cell 15, 448–461, September 16, 2008 ª2008 Elsevier Inc. 453
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Role of SRF in Sprouting Angiogenesisgenes implicated in the Notch signaling pathway in ECs, such as
Notch1, Dll4, and Nrarp1, were not affected, with the exception
of Hey2, which was downregulated. We obtained similar results
with RNA from the head (data not shown). Western blot analysis
showed a 25%–30% reduction in protein levels for SRF, VE-cad-
herin, b-actin, and ZO-1 in the mutant limb buds at E12.5, in
agreement with the decreased expression level of correspond-
ing mRNAs (Figures 5B and 5C). Other proteins, such as
VEGFR2 and connexin-43, showed no significant decrease.
Although b-actin is a known target of SRF, it is expressed in all
cell types. Whether SRF controls EC-specific gene expression
remains unresolved. On analyzing the promoter region (5 kb
to +1 kb) of the 21 downregulated genes, we found 18 presenting
conserved CArG boxes between mouse and rat or mouse and
human sequences (Table S1). Nine of the 21 had already been
identified as SRF targets in previous studies on other tissues
(Sun et al., 2006), and 12, including VE-cadherin, Alk1, Alk5, en-
doglin, and Vegfr2, represent potential new SRF targets in ECs.
Chromatin immunoprecipitation (ChIP) experiments were per-
formed in immortalized mouse brain ECs by using an SRF anti-
body. Interestingly, we found that SRF can bind to the three
CArG boxes identified at the proximity of the VE-cadherin tran-
scription start site (Figure 5D). We also found SRF interaction
on putative CArG boxes for three other tested genes (Alk1,
Alk5, and endoglin, Figure 5D; data not shown). In order to inves-
tigate a potential role of these CArG boxes in VE-cadherin ex-
pression, we inserted a 700 bp fragment containing two CArG
boxes (4064 and 3715) upstream of the 2.2 kb VE-cadherin
promoter linked to luciferase. Analysis of luciferase activity indi-
cated that mutation of the CArG box at 4064 significantly re-
duced the luciferase activity (Figure S2). In addition, we ob-
served that the CArG boxes were needed for the promoter
response toward VEGF and FGF. Our results suggest that VE-
cadherin is a direct target of SRF in ECs.
Decreased Filopodia Number and Alteration
in Filamentous Actin Organization of Endothelial Tip
Cells in SRFECKO Embryos
The defects observed at the tip of sprouting vessels in mutant
embryos prompted us to investigate the endothelial tip cells. En-
dothelial tip cell functions are tightly linked to the cytoskeleton
dynamics. Our RT-PCR and western blot analyses showed
a downregulation of b-actin in SRFECKO embryos. To visualize
the actin cytoskeleton in tip cells, we focused our analysis on
neural capillary sprouting given that the surrounding neural cells
express low-level actin compared to mesenchymal cells in other
regions of the embryo. We performed whole-mount immunos-
taining in the isolated hindbrain region of E11.5 embryos, by us-
ing isolectin B4 and phalloidin to label ECs and F-actin, respec-
tively (Figure 6; Movies S6–S12). There was a clear reduction in
the phalloidin signal at the level of the cortical actin underlying
the EC membrane in both stalk (Figures 6B and 6D, arrows)
and tip cells (Figures 6F and 6H, arrowheads). Aggregates of
phalloidin-labeled F-actin were often observed at the base of fi-
lopodia extensions in the mutant tip cells (Figure 6H). Although
the number of tip cells showed no change in SRFECKO embryos
(control: 21.13 ± 3.49 tip cells/mm2; mutant: 19.54 ± 3.89 tip
cells/mm2; n = 60, p = 0.626), we did observe a significant de-
crease in the number of filopodia extensions per tip cell (control:454 Developmental Cell 15, 448–461, September 16, 2008 ª2008 El6.56 ± 0.39; mutant: 4.98 ± 0.38; n = 72, p = 0.001). These filopo-
dia also appeared thinner and less ramified (Figure 6G). Interest-
ingly, vessel tips displayed a ballooned morphology in the
SRFECKO mutant, with several stalk cells accumulating behind
the tip cells (Figures 6C and 6G, stars) instead of the thin and
straight vessels in controls (Figures 6A and 6E). Furthermore,
we could detect more severe dilatations of the tip of some capil-
laries, which probably led to the aneurysmal structures observed
in older stages of development (Movies S7 and S10). Our in vivo
results could raise the question of whether SRF is more impor-
tant for tip cell function or stalk cell function. To address this
question, we used the aortic ring explant assay (Figures 6S–
6X). We found that aortic rings explanted from Sf/Sf mice that
were infected by the Cre-GFP adenovirus presented a mosaic in-
activation of SRF in ECs. The observation of GFP labeling indi-
cated that SRF-deficient cells could be recruited both as tip cells
or stalk cells at the early time points. However, in both cases, the
cells lacking SRF did not move over time and were either ex-
cluded from the sprouts or formed dilated glomerular structures
at the tip of the sprout that were similar to the altered vessel tips
observed in vivo (Figures 6S–6X). Infection with control GFP ad-
enovirus did not alter the movements or the inclusion of the in-
fected cells in the sprouts (data not shown).
Disrupted Interendothelial Junctions inMutant Embryos
RT-PCR and western blot analyses showed the downregulation
of several cell-cell junction proteins, including VE-cadherin and
ZO-1. ZO-1 and VE-cadherin immunostaining of neural tube
capillaries was reduced and showed a diffuse and dot-like pat-
tern in SRFECKO capillaries, in contrast to the linear pattern ob-
served in control EC membranes (Figure 6, compare [J] and [L]
to [I] and [K], arrowheads). However, we observed no changes
in VE-cadherin or ZO-1 staining in large vessels, including the ca-
rotid and the aorta (data not shown). In addition, we observed no
difference in PECAM1 localization and immunofluorescence in-
tensity levels between the control and mutant ECs of large and
small vessels (Figures 3 and 4), in agreement with the normal ex-
pression levels of Pecam1 measured by RT-PCR. Electron mi-
croscopy analysis of mutant and control E12.5 limb bud sections
confirmed the alteration of interendothelial cell junctions, with
shorter complexes compared to control vessels (Figures 6M–
6R). We also detected a decrease in the number of adherens
and tight junctions in mutant compared to control embryos,
with a reduced electronic density at the level of the adherens
junctions (arrows), suggesting a potential decrease in protein
concentration in these regions. Moreover, large gaps could be
observed (Figure 6N, asterisk) between the membranes of
ECs, compared to the tight attachment seen in the control sec-
tions at this stage of embryogenesis (Figure 6M). Altogether,
our results suggest a modification of EC junctions in the small
vessels of SRFECKO mutant embryos.
siRNA-Mediated Knockdown of SRF Impairs VEGF-
and FGF-Induced VE-Cadherin Expression, ERK1/2
Phosphorylation, and In Vitro Angiogenesis
To further characterize the role of SRF in EC biology, we knocked
down SRF by using a small interfering RNA (siRNA) in primary
human dermal microvascular ECs (HDMECs) and immortalized
human bone morrow ECs (HUBMECs). siRNA treatment led tosevier Inc.
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Role of SRF in Sprouting AngiogenesisFigure 6. Alterations in Filamentous Actin
Organization and Tip Cell Morphology in
SRFECKO Embryos
(A–H) Confocal Z-stack projections of hindbrain
capillaries of E11.5 (A, B, E, and F) control and
(C, D, G, and H) mutant embryos. The hindbrains
were stained by isoletinB4 (ECs, green) and
phalloidin (F-actin, red). In the mutant hindbrain
capillary, the intensity of F-actin staining was de-
creased, and the cortical actin cytoskeleton pres-
ents as a diffuse and dot-like structure, revealing
an alteration in the actin cytoskeleton. The inten-
sity of F-actin labeling in the filopodia extension
(arrowheads) of tip cells was reduced in mutant
embryos. (E and F) In control embryos, tip cells
are at the edge of a monocellular linear structure.
In mutants, however, the endothelial tip cells
have a balloon-like morphology, (G and H) with
an increased number of cells below the filopo-
dia-protruding cell, as revealed by the DAPI-
stained nuclei indicated by stars.
(I–L) Confocal images of (I and J) ZO-1 and (K and
L) VE-cadherin immunofluorescence of control
and mutant neural tube capillaries at E11.5.
Compared to (I and K) control capillaries, ZO-1
and VE-cadherin labeling of (J and L) mutants
was diffuse and localized in dot-like structures
(arrowheads), suggesting an alteration in interen-
dothelial junctions.
(M–R) Electron microscopy micrographs of (M, O,
and Q) control and (N, P, and R) mutant limb bud
capillaries at E12.5. The interendothelial junctions
frequently showed shorter lengths (bracketed
regions) in mutant embryos. We observed a
decrease in the number of junctional complexes
with a reduced density (arrows), as well as the
occurrence of holes between ECs (asterisk) in
some capillaries of mutant embryos. N, nuclei; l,
lumen of the vessels.
(S–X) Aortic ring assay. Microscopic pictures of
sprouting vessels from aortic ring explants of
Sf/Sf mice infected with Ad-Cre-GFP virus, in
Matrigel. (S–U) In different experiments, we could
observe that SRF-deleted cells (GFP-expressing
cells; green cells) were found both in the tip or stalk
position within the sprouting vessel alongside
control cells. However, the growth of the sprouts
containing GFP-positive cells was impaired com-
pared to control vessels in areas containing no
SRF-deleted cell. This result suggests that the
SRF-deficient cells can be recruited to sprout
either as tip or stalk cells. However, the SRF-defi-
cient cells compromise the normal migration of the
vessel, even if the SRF-deficient cell is in a stalk position. (V–X) Moreover, when only one GFP-positive cell is in the stalk position, the defective expression of SRF
leads to vessel growth arrest and an accumulation of cells in a glomerular form.
The scale bars are 10 mm in (A)–(D), 300 nm in (E)–(J), 25 mm in (I)–(L), 10 mm in (M)–(R), and 10 mm in (S)–(X).a 80% decrease of Srf RNA and a 60% reduction of SRF protein
(Figures 7A–7C). Immunofluorescence with an anti-SRF anti-
body confirmed a total of 80% of cells without SRF staining
(Figure S3). VEGF165 treatment significantly stimulated the
SRF expression in these ECs (Figures 7A–7F and data not
shown). The Srf mRNA level rapidly increased, reaching a maxi-
mum 30 min after VEGF treatment (Figure 7A). The SRF protein
level also increased, reaching a maximum 2 hr after stimulation
(Figures 7B and 7C). A luciferase reporter assay in ECs revealedDevelopmethat two CArG boxes, located in the 50 proximal region of the SRF
promoter, were needed for VEGF- or FGF-induced SRF expres-
sion (Figure S4). Deletion or mutation of these sites severely
decreased the luciferase activity in both the basal condition
and in VEGF- or FGF-stimulated cells.
Furthermore, we found a similar pattern of VE-cadherin ex-
pression and SRF expression at both the mRNA and protein
levels in response to VEGF (Figures 7A–7C). We obtained similar
results when cells were treated with bFGF (Figure S5). The Srfntal Cell 15, 448–461, September 16, 2008 ª2008 Elsevier Inc. 455
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Role of SRF in Sprouting AngiogenesisFigure 7. SRF Knockdown Impairs VEGF-Induced VE-Cadherin Expression, ERK1/2 Phosphorylation, and In Vitro Angiogenesis
(A) Quantification of relative mRNA levels of Srf, VE-cadherin, b-actin, and VEGFR2 in VEGF-stimulated HDMECs treated with scrambled siRNA (siControl, black
line) or siRNA against SRF (siSRF, gray line). The error bars represent SEM; N = 4.
(B) Representative western blot analysis of SRF, VE-cadherin, b-actin, phospho-ERK (p-ERK), and total-ERK (t-ERK) from VEGF-stimulated HDMECs treated
with scrambled siRNA or Srf siRNA.
(C) Quantification of the relative protein levels of SRF, VE-cadherin, b-actin, and p-ERK/t-ERK. The error bars represent SEM; N = 3.456 Developmental Cell 15, 448–461, September 16, 2008 ª2008 Elsevier Inc.
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Role of SRF in Sprouting AngiogenesissiRNA treatment led to a decrease in the expression of VE-cad-
herin and b-actin at the mRNA level, in correlation with the in vivo
data (Figure 7A). The western blot data reveal a significant
change in the VE-cadherin protein level, but not for b-actin,
possibly due to its high stability (Figures 7B and 7C). Activation
of SRF in ECs by VEGF has previously been shown to require
ERK signaling (Chai et al., 2004). Interestingly, knockdown of
the SRF protein level led to a decrease in MAPK/ERK1/2 phos-
phorylation in both basal and VEGF- or FGF-stimulated condi-
tions (Figures 7B and 7C; Figure S5).
Immunofluorescence analysis indicated a decreased labeling
of VE-cadherin and F-actin in ECs lacking SRF (Figure 7).
Furthermore, we observed that VEGF stimulation increased the
nuclear level of SRF and actin stress fibers (Figure 7F). These re-
sults demonstrate the importance of SRF in actin expression and
dynamics, as well as VE-cadherin expression in ECs. Knock-
down of SRF in ECs decreased cell migration (Figures 7H–7L)
and inhibited the formation of tube-like structures in a Matrigel
angiogenesis assay (Figures 7M–7Q). To address the question
of whether SRF-deficient cells can be rescued by the presence
of wild-type cells to incorporate tubular structures, we mixed
control and SRF-depleted cells (1:1) prior to culture in Matrigel.
The quantification of the total tube length of the mixed culture
was less than 50% of the control tube length (Figures 7O and
7Q). Moreover, more than 90% of the cells in the tubular struc-
tures were derived from the control culture, as assessed by the
detection of the fluorescent-labeled, scrambled siRNA (data
not shown). These results show that the SRF-deficient cells
have a cell-autonomous defect that prevents them from integrat-
ing tubular structures in vitro.
DISCUSSION
Our results reveal a key role of SRF in the angiogenic process
and the maintenance of vascular integrity. Here, we have re-
vealed that at early embryonic stages, SRF expression in ECs
is restricted to vessels of small diameter: the capillaries, arteri-
oles, and venules. Interestingly, we observed that both stalk
and tip cells strongly express SRF, indicating an important role
in sprouting angiogenesis. In SRFECKO embryos, we observed
no obvious defects in vasculogenesis. Nor did we find an alter-
ation in the early steps of angiogenesis that proceed from the
remodeling of a pre-existing capillary plexus up to E10 in
SRFECKO embryos. However, loss of the floxed Srf allele in ECs
resulted in a decreased capillary density, the formation of aneu-
rysmal structures in different regions, and, ultimately, multifocal
hemorrhages and death around E14.5. Thus, SRF is important
for sprouting angiogenesis and small vessel integrity in the
mouse embryo.DevelopmeTheControl of Actin andVE-Cadherin Expression by SRF
Is Essential in Sprouting Angiogenesis
One of the hallmarks of SRFECKO embryos is the important re-
duction in the number of branching points and capillary density.
This reduction of the network complexity is often linked to de-
fects in endothelial tip cell specification and migratory proper-
ties. In vertebrates, endothelial tip cells are located at the grow-
ing end of the capillary sprout, lack a lumen, and extend
numerous long filopodia to explore growth factor signals and
guidance cues in the surrounding tissue (Gerhardt et al., 2003).
Tip cell fate is regulated in part by the Notch pathways that func-
tion as a negative feedback mechanism to ensure appropriate
vessel patterning and prevent excessive vessel sprouting
(Roca and Adams, 2007; Gridley, 2007). Deletion of Notch ligand
Dll4 or Notch1 leads to an increase of tip cells and capillary
density (Suchting et al., 2007; Hellstro¨m et al., 2007). In contrast,
in SRFECKO mutants, no change in tip cell number and Notch1 or
Dll4 expression were observed (Figure 5). Thus, SRF seems
dispensable for tip cell fate.
The whole-mount phalloidin staining of F-actin in neural and
tail capillaries revealed an altered organization of the actin cyto-
skeleton in ECs (Figure 6; Movies S6–S12). The tip cells of the
SRFECKO embryos showed thinner and less numerous filopodia
compared to control, with a spotty phalloidin signal at the base
of the filopodia, suggesting a disorganized actin cytoskeleton
in this region. Interestingly, this defect was found not only in tip
cells, but also in stalk cells. In addition, siRNA-mediated SRF
knockdown decreased F-actin formation and impaired EC mi-
gration and the formation of tube-like structures in vitro (Figure 7).
Using the aortic ring assay, we demonstrated that mosaic dele-
tion of SRF in ECs of Sf/Sf mice, induced by the adenovirus Cre-
GFP, impaired the migration and elongation of vessel sprouts
(Figure 6). Altogether, our results suggest that SRF is required
for proper vessel migration. Interestingly, the angiogenic pheno-
type of the SRFECKO embryos is somewhat reminiscent of Dro-
sophila bearing a mutation in the Dsrf, also known as blistered
or pruned, expressed in tracheal tip cells (Guillemin et al.,
1996). The formation of the ramified tracheal respiratory system
ofDrosophila shares some similarities with the vertebrate vascu-
lar system. Mutation of the Dsrf gene or DMRTF, which encodes
a SRF cofactor activated by actin polymerization, reduces the
branching and extension of terminal branches of the tracheal
system (Guillemin et al., 1996; Somogyi and Rørth, 2004). Fur-
thermore, this phenomenon is directly dependent on the hypoxia
of surrounding tissues, which promotes the tracheal terminal
branching via the FGF-FGFR-SRF-MRTF pathway (Centanin
et al., 2008).
Moreover, previous studies have shown that SRF inactivation
in different tissues, including heart, smooth muscle, and(D–G) Confocal images of VE-cadherin (gray), phalloidin (red), and SRF (green) immunolabeling of (D and E) nonstimulated and (F and G) VEGF-stimulated
HDMEC cells. (E and G) Knockdown of SRF with siSRF decreased F-actin and VE-cadherin staining compared to (D and F) control cells treated with siControl.
VEGF increased the formation of stress fibers in the control cells, but not in SRF-deficient cells. Inserts show the cell nucleus revealed by the DAPI staining in
(D)–(G). The scale bars are 20 mm in (D)–(F).
(H–K) Monolayer scratch wound healing assay in HDMECs treated with either (H and I) scrambled siRNA or (J and K) Srf siRNA.
(L) Quantification of cell migration in the wound healing assay. The error bars represent SEM; N = 6. ***p < 0.001.
(M–P) In vitro angiogenesis assay on Matrigel with HDMECs in (M) 0.5% SVF medium or (N–P) VEGF165 (50 ng/ml)-supplemented medium. (N) Cells treated with
scrambled siRNA. (O) A mixture (1:1) of scrambled siRNA or Srf siRNA-treated cells. (P) Srf siRNA-treated cells.
(Q) Quantification of in vitro angiogenesis. Control cells did not rescue the capacity of SRF-deficient cells to form the tube-like structure.
The error bars represent SEM; N = 4. *p < 0.05; ***p < 0.001.ntal Cell 15, 448–461, September 16, 2008 ª2008 Elsevier Inc. 457
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Role of SRF in Sprouting Angiogenesisneurons, not only affects actin expression levels, but also actin
filament treadmilling (Parlakian et al., 2005; Mericskay et al.,
2007; Kno¨ll et al., 2006). The actin cytoskeleton constantly re-
models in migrating ECs, forming different structures, including
filopodia, lamellipodia, and stress fibers (Lamalice et al., 2007).
Actin treadmilling is actively regulated by small GTPases of the
RhoA family that control the organization of actin during cell mi-
gration and play an important role downstream of VEGFR2 acti-
vation by VEGF (Lamalice et al., 2004; Ridley, 2006). Indeed, cell
locomotion depends on RhoA-stimulated actomyosin contrac-
tion at the rear part of the cell (Pollard, 2003). Interestingly,
RhoA has been shown to play a major role in SRF activation of
the b-actin promoter (Sotiropoulos et al., 1999). Therefore, the
impaired tip cell migration observed in SRFECKO embryos could
be related to a deficient contractile apparatus. Interestingly, we
have shown that VEGF promotes SRF expression in cultured
ECs, and that this induction depends on the presence of CArG
boxes in the SRF promoter region (Figure 7; Figure S4). This is
in agreement with an earlier study, carried out by Tarnawski’s
group, demonstrating that SRF is activated by VEGF through
both RhoA and MEK/ERK signaling pathways (Chai et al.,
2004). In addition, we have shown that SRF is also important
for VE-cadherin expression (Figures 5–7; Figures S2 and S5).
VE-cadherin also plays an important role in mediating VEGF-
VEGFR2 signaling (Lampugnani and Dejana, 2007; Vestweber,
2008), and its downregulation in the capillaries of SRFECKO em-
bryos may also impair the VEGF response in ECs. It is of interest
to note that VEGF is highly induced by regional hypoxia, and this
pathway represents one of the major forces promoting angio-
genesis throughout the embryo (Shweiki et al., 1992). Thus,
SRF could be an important mediator in hypoxia-induced angio-
genesis in the mouse, as in the tracheal terminal branching of
Drosophila.
The vascular and neural systems share several molecular path-
ways involved in sprouting selection, guiding, and cell migration,
including VEGF and Eph-ephrin signaling (Eichmann et al., 2005).
Targeted inactivation of SRF in neurons was shown to impede
neurite outgrowth and guidance mediated by EphA repulsive sig-
nals, as well as to downregulate EphA4 and EphA7 genes (Kno¨ll
et al., 2006). More recently, Ginty’s group has shown that SRF is
a major effector of both MEK/ERK and MAL signaling by NGF and
is a key mediator of NGF-dependent target innervation by embry-
onic sensory neurons (Wickramasinghe et al., 2008). Interest-
ingly, we observed a downregulation of the genes encoding the
angiogenic guidance molecule ephrin-B2 and EphB4 receptor
in the limb buds of SRFECKO embryos, which could be implicated
in impaired vessel pathfinding in SRFECKO.
Dilatation of Capillaries in the SRFECKO Embryo
In addition to the tip cell defect, the vessel sprouts displayed
a ballooned morphology with an accumulation of flattened ECs
behind the tip cells (Figure 6; Figure S3). A similar distension of
vessel tips has been observed in the hindbrains of embryos lack-
ing heparin-binding VEGFA (Ruhrberg et al., 2002), reinforcing
the idea that SRF is an important mediator of VEGF signaling. In-
terestingly, the sites of dilatation were not randomly distributed,
but were instead found preferentially at the tip of the tail, in the
marginal vein of the limb bud, and in the neural and perineural tis-
sue (Figures 2 and 4), at least at the early stages of embryonic458 Developmental Cell 15, 448–461, September 16, 2008 ª2008 Eldevelopment. These peripheric regions, where the arterial and
venous vessels make connections, may be the sites of more
intense hemodynamic stress. These connections are defective
in the SRFECKO mutant due to the deficient sprouting angiogen-
esis. In addition, the decreased vascular branching may enhance
hemodynamic stress that would contribute to the appearance of
more severe vascular defects, such as hemorrhages and aneu-
rysms. Movies focused on the marginal vein of limb buds
showed an altered blood flow in this region, in agreement with
the additional hemodynamic burden hypothesis (Movies S1–
S4). Similarly, our detailed analysis of the tail and neural capillary
sprouts agrees with the hypothesis that a weakened cytoskele-
ton in the SRF-deficient stalk ECs may impair their resistance
to increased hemodynamic stress.
The recruitment of vascular mural cells, pericytes (PC), and
vascular SMCs (vSMC) is an important step toward vessel
stabilization. PDGF-B and its receptor play an important role in
vSMC/PC cell recruitment and proliferation during vascular
growth, as well as in the TGF-b pathway. In addition, PDGF-B-
and PDGFRb-deficient mice developed numerous capillary
microaneurysms that ruptured at late gestation (Hellstro¨m et al.,
1999). We observed a significant downregulation of these two
genes in the SRFECKO embryo, suggesting that a defect in recruit-
ment of mural cells could be implicated in the phenotype of
mutant embryos. However, whole-mount staining of neural capil-
laries for NG2, a PC-specific marker, and for smooth muscle
a-actin, a vSMC marker, showed no major differences in PC or
vSMC coverage of the vasculature between control and SRFECKO
embryos, arguing against defective mural cell recruitment as
a cause in this phenotype (Figure S6; Movies S13 and S14).
Altered Endothelial Cell-Cell Junctions
in the SRFECKO Embryo
In parallel to the decreased expression of the b-actin gene, the
deletion of Srf in ECs resulted in the decreased expression of
genes implicated in transcription and integrin signaling, as well
as those encoding cytoskeletal proteins, junction proteins, and
growth factors and their receptors. Among the affected genes,
we identified 12 new potential SRF target genes that have never
before, to our knowledge, been described. Results from our
quantitative RT-PCR, ChIP experiments, and luciferase reporter
analysis suggest the potential direct regulation of some EC-spe-
cific genes such as VE-cadherin,Alk1,Alk5, and endoglin by SRF
(Figure 5; Figure S2; data not shown). Analysis of the junction
proteins VE-cadherin and ZO-1 revealed a disorganized pattern
and a decreased protein expression in SRFECKO embryos. Elec-
tron microscopy analysis revealed the severe alteration of junc-
tional complexes that link ECs together, in capillaries (Figure 6).
Our results demonstrate that VE-cadherin, a major endothelial-
specific adhesion molecule controlling cellular junctions and
blood vessel formation (Vestweber, 2008), is a SRF target. The
decreased VE-cadherin expression and its disorganization could
influence not only the capillary integrity, but also sprouting angio-
genesis. Recently, Affolter’s group demonstrated the presence
of ‘‘dot-like’’ and short ‘‘line-like’’ ZO-1- and VE-cadherin-con-
taining structures in the migrating tip cells during intersegmental
vessel formation of zebrafish embryos. These tip cells first con-
tact each other and establish a VE-cadherin-containing interface
that is then enlarged such that adjacent tip cells make extensivesevier Inc.
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role in anastomosis and suggests that anastomosis defects may
also be responsible for the vascular defects observed in the
SRFECKO embryos. Interestingly, two other genes, Alk1 and
endoglin, mediating the TGF-b pathway, and with known in-
volvement in hemorrhagic telangiactasia disease (HHT) type 1
and type 2, respectively, were also downregulated in mutant
embryos (McAllister et al., 1994; Johnson et al., 1996). These
endothelial junctional and signaling defects, in addition to the im-
paired cytoskeleton, likely contribute to the defect in the ERK
phosphorylation observed in the SRF-deficient ECs (Figure 7)
and to the appearance of hemorrhages and aneurysms ob-
served in SRFECKO embryos (Figures 2 and 4). Taken together,
our data have shown that SRF is important for the correct forma-
tion of cellular junctions in ECs. SRF inactivation leads to the
weakening of the EC junctions and, consequently, to the desta-
bilization of vessel cytoarchitecture, ultimately leading to hemor-
rhage and aneurysm.
In conclusion, we have demonstrated here that SRF plays an
essential role in the endothelium, particularly in sprouting angio-
genesis. Taking together our results and the current knowledge
within this field, we propose the schematic model of SRF function
in ECs during angiogenesis depicted in Figure S7. In response to
angiogenic signals such as VEGF and FGF, SRF expression and
activity in ECs is induced via both RhoA and MEK/ERK signaling
pathways. SRF then increases not only the expression of its EC
target genes, such as b-actin and VE-cadherin, but also en-
hances F-actin formation. In this way, SRF favors vessel stability
and EC migration, promoting normal angiogenesis. SRF inactiva-
tion in ECs leads to a decreased expression of genes involved in
EC function, including VE-cadherin and b-actin. The misexpres-
sion of such proteins could impair RhoA- and MEK/ERK-depen-
dent biological functions in ECs. Consequently, SRF inactivation
in ECs impairs the response to angiogenic signals, migration,
and the integrity of cellular junctions of ECs, ultimately inducing
malformations of the vascular network characterized by reduced
capillary density, aneurysms, and hemorrhages. It is reasonable
to assume that SRF is an important transcription factor in ECs,
functioning downstream of VEGF signaling and/or other
pathways such as FGF, to promote cytoskeleton and junctional
reorganization, which are important for cell rearrangement, loco-
motion, and vessel integrity.
EXPERIMENTAL PROCEDURES
Targeting Inactivation of the Srf Gene in Embryonic Endothelial
Cells
Intercross of the previously described SRF-floxed (Sf/Sf) and Tie1-Cre trans-
genic mice (Parlakian et al., 2004; Gustafsson et al., 2001) gave rise to double
transgenic mice (Sf/+:Tie1-Cre). The Sf/+:Tie1-Cre male mice and the Sf/Sf
female mice were then crossed to obtain Sf/Sf :Tie1-Cre mutant embryos.
Genotyping of the mice and floxed Srf allele excision were performed by
PCR as described previously (Parlakian et al., 2004). ROSA26 Cre reporter
mice and Vim-LacZ transgenic mice have both been described previously
(Soriano, 1999; Colucci-Guyon et al., 1994). This study conformed to institu-
tional guidelines for the use of animals in research.
Histological Analysis, X-Gal Staining, and Immunohistochemistry
All embryos were staged as day 0.5 by the presence of a vaginal plug. These
experiments were performed as described previously (Parlakian et al., 2004)
and in Supplemental Data.DevelopmeQuantification and Statistical Analysis
In tip cell quantification, we blind-scored tip cells as previously described (Hell-
stro¨m et al., 2007). We used ten fields sized 455 3 455 mm per hindbrain and
six hindbrains/group (SRFECKO and control). In filopodia protrusion quantifica-
tion, we scored the filopodia bursts from 12 tip cells for each hindbrain (6 hind-
brains/group). Branching point measurements were counted in 20 confocal
fields sized 455 3 455 mm in 6 hindbrains/group or 4 limb buds/group. For
branching point measurements of the intersomitic region, we scored branch-
ing points in six intersomitic regions, in the eight limb buds from four anti-
PECAM1, whole-mount, immunolabeled embryos and four X-gal-stained
embryos. All quantitative data were analyzed by using Fisher post hoc tests
for repeated measures and Student’s unpaired t tests for comparison with
control mice at specific times. The data shown are means ± SEM. p values
< 0.05 were considered statistically significant.
Electron Microscopy
Tissue samples from limb buds were fixed in solution containing 2% parafor-
maldehyde, 1.5% glutaraldehyde, and 0.1 M phosphate buffer; postfixed for 1
hr at 4C with 2% osmium tetroxide and 2% uranyl acetate solution; dehy-
drated in a series of alcohol; and embedded in epoxy resin. Sections were
viewed by transmission electron microscopy.
Quantitative RT-PCR Assay
Forelimbs, heads, and dorsal sections were collected from fresh-harvested em-
bryos at different time points. After genotyping, total RNA was extracted from
each embryonic sample by using the MicroRNA kit (QIAGEN). The first-strand
cDNA synthesis and PCR analysis were performed as previously described
(Parlakian et al., 2005). Primer sequences are listed in Supplemental Data.
Western Blot Analysis
Western blot analysis was performed as described previously (Parlakian et al.,
2005) by using the following different antibodies: SRF (1:200), ZO1 (1:200), VE-
cadherin (1:200, BD Bioscience; 1:250, BV9, Santa Cruz), connexin43 (1:400,
BD Bioscience), VEGFR2 (1:500, Cell Signaling), b-actin (1:400, Sigma), ERK1/
2, p-ERK1/2 (Thr202/204) (1:1000, Cell Signaling), and anti-GAPDH (1:400,
Santa Cruz).
Aortic Ring Assay
C57/BL6 Sf/Sf mice were euthanized, and thoracic aortic rings (1 mm) were
isolated and incubated in MCDB131 medium with 10% FBS for 16 hr in the
presence of either adenovirus Cre-GFP or GFP and were then embedded in
growth factor-reduced Matrigel (BD Bioscience) overlaid with MCDB131 me-
dium supplemented with 2 mM Glutamax (Invitrogen), 10 U/ml heparin, 100 U/
ml penicillin, 100 mg/ml streptomycin, 10% FBS, and VEGF (50 ng/ml). Micro-
vessel outgrowth was visualized by microscopy at different time points.
Matrigel Angiogenesis Assays
Primary human dermal microvascular ECs ([HDMECs], purchased from Pro-
mocell), transfected with scrambled siRNA or anti-Srf siRNA, were plated in
24-well plates, precoated with 300 ml growth factor-reduced Matrigel (BD
Bioscience), at 50,000 cells/well. Cells were cultured in MCDB131 medium
supplemented with 2 mM Glutamax (Invitrogen), 10 U/mL heparin, 100 U/mL
penicillin, 100 mg/mL streptomycin, and 0.5% SVF. Additionally, cells were
stimulated with VEGF (50 ng/ml) or bFGF (50 ng/ml). A total of 16 hr after seed-
ing, photographs of representative 103 fields were taken and the lengths of
the endothelial tubes were measured.
Wound Healing Assay
Primary HDMECs, transfected with scrambled siRNA or anti-Srf siRNA, were
plated in 12-well plates at 50,000 cells/cm2 and were allowed to grow until
confluence. The wound was created by using a pipette cone. Then, cells
were washed once with culture medium and were allowed to migrate
in DMEM/0.5% FBS. The wounded area was monitored over the course of
24 hr, and micrographs were taken every 4 hr.
Growth Factor Simulation Assay
Primary HDMECs and HuBMEC lines were plated in 12-well or 6-well plates at
50,000 cells/cm2 and were cultured in EC growth medium MV2 (Promocell)ntal Cell 15, 448–461, September 16, 2008 ª2008 Elsevier Inc. 459
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Role of SRF in Sprouting Angiogenesisover the course of 24 hr. Afterward, the medium was replaced with DMEM/
0.5% FBS overnight, and cells were then left untreated or stimulated with
VEGF (50 ng/ml) or bFGF (50 ng/ml). Protein samples were extracted with
Kinexus buffer, and mRNA was extracted with Trizol reagent (Invitrogen) as
indicated by the manufacturer’s protocol.
SUPPLEMENTAL DATA
SupplementalData includeExperimentalProcedures,a table, figures,andmovies
and can be found with this article online at http://www.developmentalcell.com/
cgi/content/full/15/3/448/DC1/.
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